WallStSmart
XCUR

Exicure Inc

NASDAQ: XCUR · HEALTHCARE · BIOTECHNOLOGY

$3.36
+1.51% today

Updated 2026-04-30

Market cap
$22.12M
P/E ratio
P/S ratio
13.61x
EPS (TTM)
$-0.79
Dividend yield
52W range
$3 – $12
Volume
0.0M

WallStSmart proprietary scores

24
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$2.00
-40.48%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 928.00% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.36M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$28.83M$0.00$500000.00$0.00$0.00
Net income$-2.58M$-16.91M$-9.70M$-4.95M$-2.90M
EPS$-0.79
Free cash flow$-35.67M$-10.36M$-2.91M$-8.56M$-1.36M
Profit margin-8.96%-1,940.20%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
XCUR$22.12M246.33.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Exicure Inc trades at $3.36. Our Smart Value Score of 24/100 indicates the stock is weak.

Frequently asked questions

What is Exicure Inc's stock price?
Exicure Inc (XCUR) trades at $3.36.
Is Exicure Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Exicure Inc (XCUR)?
The analyst target price is $2.00, representing -40.5% downside from the current price of $3.36.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio13.61x
ROE-92.50%
Beta4.02
50D MA$3.98
200D MA$4.98
Shares out0.01B
Float0.00B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years